News | January 18, 2007

Study Aimed at Causes, Prevention of PAD

Jan. 19, 2007 — The University of Pennsylvania Health System and Life Line Screening, the nation's largest provider of mobile preventive health screenings, are collaborating to identify and recruit patients with Peripheral Arterial Disease (P.A.D.) for a pilot study on the causes and prevention of this common yet under-treated vascular disease.

"P.A.D. has a strong correlation to coronary heart disease and carries a higher risk of stroke and heart attack," says Dr. Emile R. Mohler III, director of Vascular Medicine, University of Pennsylvania Health System. "As we develop a greater understanding of how P.A.D. progresses, we'll be better equipped to help patients by determining when and how to treat them."

Using noninvasive ultrasound imaging, the research will begin to pinpoint the exact cause and progression of claudication, or outward symptoms of P.A.D., which include cramps, tiredness or pain in the legs and buttocks occurring when blood flow is restricted by atherosclerosis

For more information visit www.lifelinescreening.com.


Related Content

News | Peripheral Artery Disease (PAD)

March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...

Home March 20, 2024
Home
News | Peripheral Artery Disease (PAD)

February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...

Home February 12, 2024
Home
News | Peripheral Artery Disease (PAD)

November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for ...

Home November 10, 2023
Home
News | Peripheral Artery Disease (PAD)

October 24, 2023 — Four years ago, following a publication based on the limited data available, the U.S. Food and Drug ...

Home October 24, 2023
Home
News | Peripheral Artery Disease (PAD)

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...

Home September 14, 2023
Home
News | Peripheral Artery Disease (PAD)

July 11, 2023 — The U.S. Food and Drug Administration (FDA) is informing healthcare providers about updated information ...

Home July 11, 2023
Home
News | Peripheral Artery Disease (PAD)

June 21, 2023 — A new science report issued by the American Heart Association (AHA) emphasizes the importance of ...

Home June 21, 2023
Home
News | Peripheral Artery Disease (PAD)

June 16, 2023 — Endologix LLC, a privately held, global medical device company, dedicated to providing disruptive ...

Home June 16, 2023
Home
News | Peripheral Artery Disease (PAD)

June 15, 2023 — Endologix LLC, a privately held, global medical device company dedicated to providing disruptive ...

Home June 15, 2023
Home
News | Peripheral Artery Disease (PAD)

March 8, 2023 — Treatments for peripheral artery disease (PAD) were largely developed in men and are less effective in ...

Home March 08, 2023
Home
Subscribe Now